PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.92%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-0.56%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-17.46%
Gross profit decline while CRON.TO shows 30.21% growth. Joel Greenblatt would examine competitive position.
-12.27%
Margin decline while CRON.TO shows 37.90% expansion. Joel Greenblatt would examine competitive position.
-0.60%
Both companies reducing R&D. Martin Whitman would check industry innovation trends.
3.07%
G&A growth 50-75% of CRON.TO's 5.71%. Bruce Berkowitz would examine operational efficiency.
7.60%
Marketing expense growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
-1.49%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
2.64%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
0.85%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
-29.59%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-2.20%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-144.55%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-5663.80%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-31.73%
Operating income decline while CRON.TO shows 6.26% growth. Joel Greenblatt would examine position.
-40.02%
Operating margin decline while CRON.TO shows 0.72% growth. Joel Greenblatt would examine position.
42.37%
Other expenses growth less than half of CRON.TO's 1034.08%. David Dodd would verify if advantage is sustainable.
-25.20%
Pre-tax income decline while CRON.TO shows 71.76% growth. Joel Greenblatt would examine position.
-33.09%
Pre-tax margin decline while CRON.TO shows 70.10% growth. Joel Greenblatt would examine position.
-262.43%
Tax expense reduction while CRON.TO shows 87.47% growth. Joel Greenblatt would examine advantage.
6.32%
Net income growth below 50% of CRON.TO's 56.59%. Michael Burry would check for structural issues.
0.42%
Net margin growth below 50% of CRON.TO's 54.02%. Michael Burry would check for structural issues.
16.67%
EPS growth below 50% of CRON.TO's 56.72%. Michael Burry would check for structural issues.
9.09%
Diluted EPS growth below 50% of CRON.TO's 56.72%. Michael Burry would check for structural issues.
8.22%
Share count reduction below 50% of CRON.TO's 0.09%. Michael Burry would check for concerns.
6.33%
Diluted share reduction below 50% of CRON.TO's 0.09%. Michael Burry would check for concerns.